ÂÜÀòÂÒÂ×

Peter Berkowitz is an accomplished finance professional with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as Finance Director for US Oncology and Global Neurology & Immunology at EMD Serono, Inc., Peter manages global P&L, supports product launches, and provides insightful analysis to inform strategic decisions. Prior roles include Senior Manager of Business Planning at Biogen Idec, where Peter enhanced forecasting processes for significant portfolios, and Associate Director of Financial Planning and Analysis at Merck, focusing on revenue forecasting and product performance analysis. Peter began a career in finance with a strong foundation as a Trader and Private Equity Analyst at BLMIS and holds an MBA in Finance from NYU Stern School of Business and a BA in Economics from Tufts University.